Gilead Sciences

CA · 52 filings, 2025

File · Money Read

What the money shows

Gilead Sciences reported $7.8M in federal lobbying for 2025 across 52 filings. The filings name 14 lobbying firms, led by Capitol TAX Partners and Jeffrey J. Kimbell & Associates. The matched PAC file shows $2,200 to 0 lawmakers. The filing text lists 7 issue areas.

Sources: Senate LDA · FEC

Lobbying spend · 2025

$7.8M

to shape legislation

Its PAC gave

$2K

◆ Gilead Sciences,Inc. PAC → 1 lawmakers

About the organization

Gilead Sciences, Inc. () is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19. It also develops medicines in therapeutic areas such as oncology and inflammation and cell therapy. via Wikipedia ↗

1Lobbies on

Health Other Foreign Banking Tech

Its filings list: Health Issues · Medicare/Medicaid · Budget/Appropriations · Trade (domestic/foreign) · Taxation/Internal Revenue Code · Copyright/Patent/Trademark · Pharmacy

2Through these firms · 14

CAPITOL TAX PARTNERS, LLPJEFFREY J. KIMBELL & ASSOCIATES, INC.FORBES-TATEW STRATEGIES, LLCTIBER CREEK GROUPTARPLIN, DOWNS & YOUNG, LLCTHE DUBERSTEIN GROUP INC.TODD STRATEGY GROUPFARRAGUT PARTNERS LLPEMPIRE CONSULTING GROUPGILEAD SCIENCES, INC.THE MCMANUS GROUPMILLER STRATEGIES, LLCTHEGROUP DC, LLC

3Shows up in these bills · 1

HR 9682Eliminate hepatitis C nationwide

4And its PAC funds these lawmakers · 1

Democrats · 0$0

No democrats on file.

Republicans · 1$2,200

RKeith Wagoner WA$2,200